Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [12071]

New study may transform diagnosis of Britain’s number one cancer

New study may transform diagnosis of Britain’s number one cancer

The role of WNT signaling in cancer: from mechanisms to therapeutics

The role of WNT signaling in cancer: from mechanisms to therapeutics

Vitamin-engineered nanoplatforms: Revolutionising precision oncology through immunotherapy, drug delivery, and theranostics

Vitamin-engineered nanoplatforms: Revolutionising precision oncology through immunotherapy, drug delivery, and...

$FDA approves revumenib for relapsed or refractory acute myeloid leukaemia with a susceptible NPM1 mutation$

FDA approves revumenib for relapsed or refractory acute myeloid leukaemia with a susceptible NPM1 mutation

$FDA approves belantamab mafodotin-blmf for relapsed or refractory multiple myeloma$

FDA approves belantamab mafodotin-blmf for relapsed or refractory multiple myeloma

Common jobs held by immigrant women may put them at increased risk of breast cancer

Common jobs held by immigrant women may put them at increased risk of breast cancer

High levels of specific protein may impair high-risk paediatric neuroblastoma

High levels of specific protein may impair high-risk paediatric neuroblastoma

Hidden immune defense mechanism could be used to fight cancer, says study

Hidden immune defense mechanism could be used to fight cancer, says study

New way to destroy a cancer-linked molecule revealed

New way to destroy a cancer-linked molecule revealed

ESMO 2025: Colon cancer DNA detectable in blood can guide chemo decisions: study

ESMO 2025: Colon cancer DNA detectable in blood can guide chemo decisions: study

More from ecancer